Primary Benefits of nutraMetrix Isotonix® Vitamin D with K2*:
- Promotes normal bone mineral density
- Promotes healthy arteries
- Supports immune health
- Helps maintain bone health
- Helps maintain bone mass by supporting normal osteoclast activity
- Helps maintain cardiovascular health
- Promotes elasticity of blood vessels
- Helps maintain normal blood pressure
- Women with low bone density have been found to be deficient in vitamin K
Key Ingredients Found in nutraMetrix Isotonix® Vitamin D with K2:
Vitamin D3 (Cholecalciferol) 5000 IU
Vitamin
D is a fat-soluble vitamin that is found in some foods and endogenously
produced when sunlight strikes the skin and activates vitamin D
synthesis. Vitamin D promotes the efficient intestinal absorption of
calcium, primarily in the duodenum and jejunum by supporting the
synthesis of calcium-binding proteins to promote normal calcium
absorption and retention. Vitamin D also promotes the normal formation
of bone and normal bone growth and bone remodeling by osteoblasts and
osteoclasts. Vitamin D deficiency can be caused by factors such as lack
of exposure to sunlight, reduced skin synthesis of vitamin D, lower
dietary intake, impaired intestinal absorption and reduced metabolism to
active forms of vitamin D by the kidneys, all of which increase with
aging. Deficiency has been linked to numerous health concerns, and
insufficient levels of this vitamin are associated with weak bones and
muscle weakness. In addition to promoting strong bones, vitamin D also
has other roles in health, including supporting the bodys normal
modulation of neuromuscular function and immune function. Vitamin D has
been shown to support immune-modulation, and it is thought that
supplementation promotes immune health by promoting the bodys normal
regulation of T-cell function. In reference to cellular health, vitamin D
supports the modulation of many genes that are responsible for encoding
proteins that regulate normal cell cycle activity. Vitamin D levels
have been strongly correlated to healthy cells. Lastly, through its
interaction with VDR (vitamin D receptor), vitamin D supports the
healthy expression of the gene encoding renin, thus helping to maintain
healthy blood pressure.*
Vitamin K2 45 mcg
Vitamin
K is a fat-soluble vitamin found in meat, eggs, dairy and natto.
Although a fat-soluble vitamin, the body stores very little K2, and its
stores are rapidly depleted without regular dietary intake. Natural
vitamin K2, also known as menaquinone-7 (MK-7), is the most bioavailable
form of K2 and has the longest half-life in the blood of any form of
vitamin K. The Japanese soy food natto is particularly rich in
menaquinone-7 (MK-7). Studies of natto consumption in Japan have linked
menaquinone-7 to bone and cardiovascular health. The correlation of
vitamin K to cardiovascular and bone health directly focuses on
supporting proper calcium utilization, whereby adequate metabolism of
calcium supports arterial and bone health. This is often referred to as
the calcium paradox. The calcium paradox is explained simply as getting
calcium in the right place (i.e., into the bone structures instead of
the arterial vessel walls.) These events are dependent upon the
synthesis of the vitamin K-dependent proteins osteocalcin and matrix Gla
protein in a process called carboxylation. The carboxylation of these
proteins is a post-translational step; that is, osteocalcin and matrix
Gla protein are translated from their respective messenger RNA and then
modified by enzymes to the active forms. These carboxylated forms
support the healthy binding and releasing of calcium. This reaction is
essential for optimal and healthy utilization of calcium. Vitamin K2
promotes the synthesis of proteins involved with calcium utilization,
thereby supporting bone retention and arterial health. While Vitamin D
supports the healthy regulation and synthesis of osteocalcin, the
mineral-binding capacity of this protein requires vitamin K-dependent
carboxylation and is thought to be related to bone mineralization. Gas6
is a vitamin K-dependent protein found throughout the nervous system, as
well in the heart, lungs, stomach, kidneys and cartilage. Although the
exact mechanism of its action has not been determined, Gas6 appears to
be a cellular growth regulator involved in cellular activities such as
cell adhesion, cell proliferation and protection against apoptosis.*
Scientific Studies Which Support nutraMetrix Isotonix® Vitamin D with K2:
· Knapen
M et al. Vitamin K2 supplementation improves hip bone geometry and bone
strength indices in postmenopausal women. Osteoporosis International.
18(7):963-72, 2007.
· Shiraki,
M., et al. Vitamin K2 (menatetrenone) effectively prevents fractures
and sustains lumbar bone mineral density in osteoporosis. Journal of
Bone & Mineral Research. 15:515-522, 2000.
· Hiruma
Y et al. Vitamin K(2) and geranylgeraniol, its side chain component,
inhibited osteoclast formation in a different manner. Biochemical
Biophysical Research Communications. 314(1):24-30, 2004.
· Plaza S and Lamson D. Vitamin K2 in bone metabolism and osteoporosis. Alternative Medicine Reviews. 10(1):24-35, 2005. Review.
· Kameda
T et al. Vitamin K2 inhibits osteoclastic bone resorption by inducing
osteoclast apoptosis. Biochemical and Biophysical Research
Communications. 220(3):515-519, 1996.
· Taira
H et al. Menatetrenone (vitamin K2) acts directly on circulating human
osteoclast precursors. Calcified Tissue International. 73(1):78-85,
2003.
Hidaka T et al. Treatment for patients with postmenopausal
osteoporosis who have been placed on HRT and show a decrease in bone
mineral density: effects of concomitant administration of vitamin K(2).
Journal of Bone and Mineral Metabolism. 20(4):235-239, 2002.
· Iwamoto J et al. Effects of vitamin K2 on osteoporosis. Current Pharmaceutical Design. 10(21):2557-2576, 2004.
· Iwamoto
J et al. Treatment with vitamin D3 and/or vitamin K2 for postmenopausal
osteoporosis. The Keio Journal of Medicine. 2003 Sep;52(3):147-50.
Review.
· Neogi,
T., et al. Low vitamin K status is associated with osteoarthritis in
the hand and knee. Arthritis and Rheumatism. 54(4):1255-1261, 2006.
Price P. Role of vitamin K-dependent proteins in bone metabolism. Annual Review of Nutrition. 8:565-583, 1988.
· Bekner K. The vitamin K-dependent carboxylase. Journal of Nutrition. 130(8):1877-1880, 2000.
· Nelsestuen G et al. Vitamin K-dependent proteins. Vitamins and Hormones. 58:355-389, 2000.
· Shearer
M. Role of vitamin K and Gla proteins in the pathophysiology of
osteoporosis and vascular calcification. Current Opinion in Clinical
Nutrition and Metabolic Care. 3(6):433-438, 2000.
· Gundberg
C et al. Vitamin K status and bone health: an analysis of methods for
determination under carboxylated osteocalcin. Journal of Clinical
Endocrinology and Metabolism. 83(9):3258-3266, 1998.
· Weber
P. Management of osteoporosis: is there a role for vitamin K?
International Journal for Vitamin and Nutrition Research. 67(5):350-6,
1997.
· Garber,
A. K., et al. Comparison of phylloquinone bioavailability from food
sources or a supplement in human subjects. Journal of Nutrition.
129(6):1201-1203, 1999.
· Binkley N et al. Vitamin K nutrition and osteoporosis. Journal of Nutrition. 125(7):1812-1821, 1995.
· Bischoff-Ferrari
Het al. Fracture prevention with vitamin D supplementation: a
meta-analysis of randomized controlled trials. JAMA.
293(18):2257-2264, 2005.
· Guirguis-Blake
J et al. Oral vitamin D3 decreases fracture risk in the elderly.
Journal of Family Practice. 52(6):431-435, 2003.
· Schaafsma,
A., et al. Vitamin D3 and vitamin K1 supplementation of Dutch
postmenopausal women with normal and low bone mineral densities:
effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin.
European Journal of Clinical Nutrition. 54:626-631, 2000.
· Trivedi
Det al. Effect of four monthly oral vitamin D3 (cholecalciferol)
supplementation on fractures and mortality in men and women living in
the community: randomised double blind controlled trial. British
Medical Journal. 326(7387):469, 2003.
· Van
den Berghe G et al. Bone turnover in prolonged critical illness:
effect of vitamin D. Journal of Clinical Endocrinology and Metabolism.
88(10):4623-4632, 2003.
· Chapuy M et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. New England Journal of Medicine. 327(23):1637-1642, 1992.
· Grant W and Holick M. Benefits and requirements of vitamin D for optimal health. Alternative Medicine Review. 10:94-111, 2005.
· Plaza S and Lamson D. Vitamin K2 in bone metabolism and osteoporosis. Alternative Medicine Reviews. 10(1):24-35, 2005. Review.
· Zitterman
A et al. Low vitamin D status: a contributing factor in the
pathogenesis of congestive heart failure? Journal of the American College of Cardiology. 41(1):105-112, 2003.
· Schleithoff
S et al. Vitamin D supplementation improves cytokine profiles in
patients with congestive heart failure: a double-blind, randomized,
placebo-controlled trial. American Journal of Clinical Nutrition.
83(4):754-759, 2006.
Argiles A et al. Blood pressure is correlated
with vitamin D(3) serum levels in dialysis patients. Blood
Purification. 20(4):370-375, 2002.
· Kristal-Boneh E et al. Association of calcitriol and blood pressure in normotensive men. Hypertension. 30(5):1289-1294, 1997.
· Li
Y et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator
of the renin-angiotensin system. Journal of Clinical Investigation.
110(2):229-238, 2002.
· Li Y et al. Vitamin D regulation of the renin-angiotensin system. Journal of Cell Biochemistry. 88(2):327-331, 2003.
· Li
Y et al. Vitamin D: a negative endocrine regulator of the
renin-angiotensin system and blood pressure. Journal of Steroid
Biochemistry and Molecular Biology. 89-90(1-5):387-392, 2004.
· Pfeifer
M et al. Effects of a short-term vitamin D(3) and calcium
supplementation on blood pressure and parathyroid hormone levels in
elderly women. Journal of Clinical Endocrinology and Metabolism.
86(4):1633-1637, 2001.
· Sigmund
C. Regulation of renin expression and blood pressure by vitamin D(3).
Journal of Clinical Investigation. 110(2):155-156, 2002.
Vasquez A
et al. The clinical importance of vitamin D (cholecalciferol): a
paradigm shift with implications for all healthcare providers.
Alternative Therapies. 10(5):28-38, 2004.
· Nimptsch K et al. Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg
cohort of the European Prospective Investigation into Cancer and
Nutrition. American Journal of Clinical Nutrition. 87:985-992, 2008.
· Habu
D et al. Role of vitamin K2 in the development of hepatocellular
carcinoma in women with viral cirrhosis of the liver. JAMA.
292(3):358-361, 2004.
· Yoshida
T et al. Apoptosis induction of vitamin K2 in lung carcinoma cell
lines: the possibility of vitamin K2 therapy for lung cancer.
International Journal of Oncology. 23(3):627-632, 2003.
· Lamson D and Plaza S. The anticancer effects of vitamin K. Alternative Medicine Review. 8(3):303-18, 2003.
Yokoyama
T et al. Combination of vitamin K2 plus imatinib mesylate enhances
induction of apoptosis in small cell lung cancer cell lines.
International Journal of Oncology. 26(1):33-40, 2005.
· Chlebowski R et al. Vitamin K in the treatment of cancer. Cancer Treatment Review. 12:49-63, 1985.
· Lamson D et al. The anticancer effects of vitamin K. Alternative Medicine Review. 8(3):303-318, 2003.
· Hitomi M et al. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo. International Journal of Oncology. 26(3):713-720, 2005.
· Nouso
K et al. Regression of hepatocellular carcinoma during vitamin K
administration. World Journal of Gastroenterology. 11(42):6722-6724,
2005.
· Blackmore
K et al. Vitamin D from dietary intake and sunlight exposure and the
risk of hormone-receptor-defined breast cancer. American Journal of
Epidemiology. 168(8):915-24, 2008.
· Deluca H et al. Vitamin D: its role and uses in immunology. FASEB Journal. 15(14):2579-2585, 2001.
Adorini
L. Immunomodulatory effects of vitamin D receptor ligands in
autoimmune diseases. International Immunopharmacology. 2(7):1017-1028,
2002.
· Cantorna
M et al. Mounting evidence for vitamin D as an environmental factor
affecting autoimmune disease prevalence. Experimental Biology and
Medicine (Maywood). 229(11):1136-1142, 2004.
· Cantorna
M. Vitamin D and autoimmunity: is vitamin D status an environmental
factor affecting autoimmune disease prevalence? Society for Experimental
Biology and Medicine. 223:230-233, 2000.
· Garland C et al. The role of vitamin D in cancer prevention. American Journal of Public Health. 96(2):252-61, 2006.
· Giovannucci
E et al. Prospective study of predictors of vitamin D status and
cancer incidence and mortality in men. Journal of the National Cancer
Institute. 98(7):451-459, 2006.
· Holick,
M. Vitamin D: Its role in cancer prevention and treatment. Progress
in Biophysics and Molecular Biology. 92(1):49-59, 2006.
· Gorham
E et al. Vitamin D and prevention of colorectal cancer. Journal
Steroid Biochemistry and Molecular Biology. 97(1-2):179-94, 2005.
· Grant
W et al. Reviews: A critical review of studies on vitamin D in
relation to colorectal cancer. Nutrition and Cancer. 48(2):115-123,
2004.
· Harris D et al. Vitamin D and colon carcinogenesis. Journal of Nutrition. 134(12):3463S-3471S, 2004.
· Hayes
C et al. The immunological functions of the vitamin D endocrine
system. Cellular and Molecular Biology. 49(2):277-300, 2003.
What Makes nutraMetrix Isotonix® Vitamin D with K2 Unique?
nutraMetrix
Isotonix Vitamin D with K2 contains vitamin D3, the metabolically
active form of vitamin D, along with vitamin K2, a form of vitamin K
which supports vascular health and calcium utilization. Vitamin D plays
an important role in bone health, heart health and immune support, while
working with vitamin K to support normal absorption of calcium and
promote healthy arteries. nutraMetrix Isotonix Vitamin D is the first of
its kind to deliver both of these powerful vitamins with isotonic
delivery.
Vitamin
K is included in nutraMetrix Isotonix Vitamin D with K2 because of its
unique partnership with vitamin D. Vitamins K and D work together to
support calcium absorption and utilization. Vitamin K supports the
normal delivery of calcium to the bones and promotes healthy arteries.
At
least two naturally-occurring forms of vitamin K have been identified
and are known as K1 and K2. While there are many similarities between
these two forms of vitamin K, they are distinguished by their important
differences. The most significant difference between K1 and K2 is their
chemical structure which results in different pharmacokinetic
properties. Vitamin K1 is retained primarily in the liver where, at high
doses, it may interfere with the action of warfarin and other
anticoagulant medications.
Vitamin
K2 has a different mechanism of action. It is transported primarily to
bones and blood vessels. Vitamin K2 helps to maintain bone mass, support
calcium utilization and promote elasticity of blood vessels.
Some
studies have concluded that vitamin K2 does not interfere with
anticoagulant medications.* However, most products containing vitamin K
(including K1 and/or K2) warn users taking anticoagulants not to take
the product. If you are currently taking warfarin or another
anticoagulant medication, you should consult your physician before
taking any product containing vitamin K1 or K2.
Isotonix
dietary supplements are delivered in an isotonic solution. This means
that the body has less work to do to obtain maximum absorption of the
nutrients. The isotonic state of the suspension allows nutrients to pass
directly into the small intestine and rapidly absorb into the
bloodstream. With Isotonix products, little nutritive value is lost,
making the absorption of nutrients highly efficient while delivering
maximum results.
Related terms: vitamin D, vitamin K, bone health, cardiovascular health, immune support, D3, K2
Frequently Asked Questions about nutraMetrix Isotonix® Vitamin D with K2:
Why is vitamin K included in nutraMetrix Isotonix Vitamin D with K2?
Vitamin
K is included in this product because of its unique partnership with
vitamin D. Vitamins K and D work together to promote healthy calcium
absorption and utilization. Vitamin K supports the delivery of calcium
to the bones and helps maintain arterial health.*
Is nutraMetrix Isotonix Vitamin D with K2 safe for people on anticoagulant medications?Some
studies have concluded that vitamin K2 does not interfere with
anticoagulant medications. However, most products containing vitamin K
(including K1 and/or K2) warn users taking anticoagulants not to take
the product. If you are currently taking warfarin or another
anticoagulant medication, you should consult your physician before
taking any product containing vitamin K1 or K2.
How do I take nutraMetrix Isotonix Vitamin D with K2?
Mix one capful of Isotonix Vitamin D with K2 with 2 ounces of water. Take one serving daily.
Is it safe to take more than 1 serving of this product daily?
One
serving daily of Isotonix Vitamin D with K2 is recommended. Check with
your physician before taking additional daily servings of this product.
Is there a toxicity level for vitamin D?
The
recommended daily Upper Limit for vitamin D is 10,000 IU, however,
safety studies indicate that up to 40,000 IU may be safe for most
people. If you wish to take more than one daily serving of this product,
you should check with your physician.
What are dietary sources of vitamin D?
Foods rich in vitamin D include cod liver oil, salmon, mackerel and tuna.
* These statements have not been evaluated by the Food and Drug Administration.
This product(s) is not intended to diagnose, treat, cure or prevent any disease.
Orlampa
Enterprises, Inc. specializes in helping individuals, groups, & companies
lose sickness and find wellness through the implementation of science based
wellness programs.
Orlampa Enterprises
also helps health care professionals implement holistic wellness programs into
their existing practices with the goal to educate both the health care
providers, their staffs, and the patients. The programs, which provide the
health care professional with a substantial additional income stream in this
ever changing medical marketplace, allow the patient to achieve true wellness
instead of receiving a traditional treatment for symptoms.
Orlampa Enterprises is an internet based product broker specializing in
personalized health and wellness related services. Orlampa Enterprises is
primed to continue its growth by duplicating its successful business model of
educating, training, and developing entrepreneurial leaders as business
partners. As an Unfranchise™ business owner, Orlampa Enterprises, proudly
utilizes highly researched products including nutraMetrix® nutritional
supplements.
Orlampa Enterprises' motto is "Eat well, exercise, and
supplement intelligently."
Contact Beth at bb@orlampa.com or 727.492.8212 for more information about
nutraMetrix® partnership opportunities available.